Sunil Healthcare
75.00
-0.50(-0.66%)
Market Cap₹76.91 Cr
PE Ratio21.70
IndustryHealthcare
Company Performance:
1D-0.66%
1M0.00%
6M0.00%
1Y0.00%
5Y0.00%
View Company Insightsright
More news about Sunil Healthcare
07Apr 26
Sunil Healthcare Limited Receives SEBI Compliance Certificate for Q4 FY26
Sunil Healthcare Limited received its quarterly SEBI compliance certificate under Regulation 74(5) for Q4 FY26 ending March 31, 2026. The certificate was issued by RTA Alankit Assignments Limited on April 4, 2026, confirming proper dematerialization procedures for equity shares. Company Secretary Satyendu Pattnaik submitted the certificate to BSE and Calcutta Stock Exchange on April 7, 2026, maintaining regulatory compliance.
 no imag found
06Feb 26
Sunil Healthcare Limited Announces Q3 FY26 Financial Results
Sunil Healthcare Limited announced its Q3 FY26 financial results showing standalone revenue of ₹2,183.73 lakhs and net profit of ₹44.30 lakhs for the quarter ended December 31, 2025. The consolidated results included foreign subsidiaries with revenue of ₹2,233.49 lakhs and net profit of ₹58.52 lakhs. For nine months, standalone revenue reached ₹6,799.69 lakhs with net profit of ₹151.82 lakhs.
 no imag found
05Nov 25
Sunil Healthcare Reports Mixed Q2 FY2026 Results with Standalone Profit and Consolidated Loss
Sunil Healthcare Limited announced its Q2 FY2026 results, showing a standalone profit but consolidated loss. Standalone revenue increased to Rs. 235.76 lakhs in Q2, with a profit of Rs. 7.90 lakhs. Half-yearly standalone revenue reached Rs. 461.96 lakhs with a profit of Rs. 50.75 lakhs. However, consolidated operations reported a Q2 loss of Rs. 5.64 lakhs and a half-year loss of Rs. 18.47 lakhs. The Board approved these results on November 4, 2025, with auditors Singhi & Co. conducting a limited review.
 no imag found
Sunil Healthcare
75.00
-0.50
(-0.66%)
1 Year Returns:0.00%
Industry Peers
Sun Pharmaceutical
1,853.10
(-0.42%)
Divis Laboratories
9,396.00
(-0.45%)
Torrent Pharmaceuticals
4,959.00
(+0.59%)
Zydus Life Science
1,134.40
(+1.49%)
Cipla
1,352.20
(-1.54%)
Laurus Labs
1,962.00
(+0.87%)
Dr Reddys Laboratories
1,161.70
(+1.64%)
Aurobindo Pharma
1,675.00
(+0.40%)
Lupin
2,092.10
(+0.69%)
Mankind Pharma
2,257.20
(+0.84%)